SEC Form 4 · accession 0001437749-18-018628
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
Oct 20, 2018
Accepted (ET)
Oct 23, 2018 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 20, 2018 | M | 23,703 | $14.11 | A | 119,941 | D | |
| Common StockF1 | Oct 20, 2018 | F | 11,751 | $14.11 | D | 108,190 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1,F3 | — | Oct 20, 2018 | M | 23,703 | D | Oct 20, 2018 | Oct 20, 2018 | Common Stock | 23,703 | 0 | D |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F2The restricted stock units were granted on October 20, 2016.
- F3The restricted stock units vested on October 20, 2018.